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Membrane Potential-generating Malate (MleP) and Citrate (CitP)
Transporters of Lactic Acid Bacteria Are Homologous Proteins
SUBSTRATE SPECIFICITY OF THE 2-HYDROXYCARBOXYLATE TRANSPORTER FAMILY*
(Received for publication, March 25, 1997, and in revised form, May 22, 1997)
Michael Bandell‡, Virginie Ansanay§, Najma Rachidi§, Sylvie Dequin§, and Juke S. Lolkema‡¶
From the ‡Department of Microbiology, Groningen Biotechnology and Biomolecular Sciences Institute, University of
Groningen, 9751NN Haren, The Netherlands and the §Laboratoire de Microbiologie et Technologie des Fermentations,
Institut des Produits de la Vigne, INRA, 2 Place Viala, F-34060 Montpellier Cedex 1, France
Membrane potential generation via malate/lactate ex-
change catalyzed by the malate carrier (MleP) of Lacto-
coccus lactis, together with the generation of a pH gra-
dient via decarboxylation of malate to lactate in the
cytoplasm, is a typical example of a secondary proton
motive force-generating system. The mleP gene was
cloned, sequenced, and expressed in a malolactic fer-
mentation-deficient L. lactis strain. Functional analysis
revealed the same properties as observed in membrane
vesicles of a malolactic fermentation-positive strain.
MleP belongs to a family of secondary transporters in
which the citrate carriers from Leuconostoc mesen-
teroides (CitP) and Klebsiella pneumoniae (CitS) are
found also. CitP, but not CitS, is also involved in mem-
brane potential generation via electrogenic citrate/lac-
tate exchange. MleP, CitP, and CitS were analyzed for
their substrate specificity. The 2-hydroxycarboxylate
motif R1R2COHCOOH, common to the physiological sub-
strates, was found to be essential for transport although
some 2-oxocarboxylates could be transported to a lesser
extent. Clear differences in substrate specificity among
the transporters were observed because of different tol-
erances toward the R substituents at the C2 atom. Both
MleP and CitP transport a broad range of 2-hydroxycar-
boxylates with R substituents ranging in size from two
hydrogen atoms (glycolate) to acetyl and methyl groups
(citromalate) for MleP and two acetyl groups (citrate)
for CitP. CitS was much less tolerant and transported
only citrate and at a low rate citromalate. The substrate
specificities are discussed in the context of the physio-
logical function of the transporters.
The electrochemical gradient of protons across the cytoplas-
mic membrane is a major store of free energy in the bacterial
cell. Usually, the proton motive force (pmf)1 is generated by
translocation of protons against the gradient across the cell
membrane which results in the two components of the pmf, a
membrane potential and a pH gradient. Proton pumping is
catalyzed by primary transport systems at the expense of some
source of chemical energy or light. In certain anaerobes a
different mechanism of pmf generation has evolved which in-
volves the action of secondary transporters rather than pri-
mary ion pumps and, therefore, is termed secondary pmf gen-
eration (for reviews, see Refs. 1 and 2). An example of such a
system is the malolactic fermentation pathway found in several
lactic acid bacteria (3–5). In Lactococcus lactis the uptake of
divalent malate is coupled to the exit of its decarboxylation
product, monovalent lactate (precursor/product exchange),
which leads to the formation of a membrane potential of phys-
iological polarity. Furthermore, the intracellular decarboxyla-
tion of malate catalyzed by malolactic enzyme consumes a
cytosolic proton which results in a pH gradient over the cell
membrane. The combined activities of electrogenic exchange
and proton-consuming decarboxylation result in a pmf that is
sufficiently high to drive ATP synthesis via the F0F1-ATPase
(3). Similar pathways have been described for a number of
other substrates (6–8). Recently, a more complex system
termed citrolactic fermentation was found in Leuconostoc mes-
enteroides, another lactic acid bacterium. Similar to the malo-
lactic fermentation pathway a secondary transporter catalyzes
the uptake of divalent citrate in exchange for monovalent lac-
tate, but the pathway in the cytosol converting citrate into
lactate requires three different enzymes and is coupled to glu-
cose metabolism (9, 10).
The membrane potential-generating secondary transporters
involved in malolactic fermentation and citrolactic fermenta-
tion, MleP and CitP, respectively, differ from “usual” secondary
transporters in two aspects: (i) they translocate net negative
charge across the membrane, and (ii) they catalyze efficient
heterologous exchange of two structurally related substrates
(the precursor and the product). Functionally, MleP and CitP
are quite similar because lactate is a substrate of both, and,
moreover, it was shown that malate is a substrate of CitP as
well (9). The structural gene coding for CitP was cloned from
different organisms (11, 12) and shown to be homologous to the
Na1-dependent citrate carrier CitS of Klebsiella pneumoniae
(13). CitS is a usual secondary transporter driven by the pmf
and sodium ion motive force (14–16). Recently, CitS was shown
to represent a new structural class of secondary transporters
with a nine-helix bundle motif (17).
Here, we report the cloning and sequencing of the mleP gene
coding for the malate transporter of L. lactis which is involved
in malolactic fermentation. In line with the functional similar-
ities of MleP and CitP the gene was found to be homologous to
the citP and citS genes. The three proteins are part of a family
of secondary transporters in which both metabolic energy-dis-
sipating (CitS) and -generating (CitP and MleP) members are
found. Essential for MleP and CitP is the ability to transport
two differently charged but structurally related molecules,
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which suggests a wide substrate specificity. It is shown that a
broad range of 2-hydroxycarboxylates can be transported by
members of the family. In line with its physiological function,
the substrate specificity of CitS is much more restricted than
observed for the two precursor/product exchangers.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions
L. lactis strains IL1403 and IL1441 are wild type malate-fermenting
strains; strains MG1363 and LL108 do not ferment malate. Strain
IL1441 is a streptomycin-resistant derivative of IL1403 (18). Strain
LL108, kindly provided by K. Leenhouts, is a chloramphenicol-resistant
derivative of MG1363 with multiple copies of the repA gene inserted in
its chromosome which results in an increase in plasmid copy number
(19). L. lactis NCDO176 is a wild type citrate-fermenting strain ob-
tained from the Dutch Institute of Dairy Research (Ede, The Nether-
lands). The L. lactis strains were grown in closed serum bottles without
shaking in M17 broth (Difco) supplemented with 0.5% (w/v) glucose and
at 30 °C. Concentrations of 5 mg/ml erythromycin and 5 mg/ml chloram-
phenicol were used when indicated. L. mesenteroides ssp. mesenteroides
19D was grown at 30 °C in MRS medium without acetate and Tween
and with 0.5% ammonium citrate (20). Escherichia coli strains DH5a,
BL21(DE3), and MC1061 were grown aerobically at 37 °C in Luria
broth supplemented with 100 mg/ml carbenicillin or 10 mg/ml chloram-
phenicol when indicated.
Recombinant DNA Techniques
Standard DNA manipulation techniques were carried out essentially
as described by Sambrook et al. (21). L. lactis genomic DNA was isolated
as described by Simon et al. (22). L. lactis and L. mesenteroides plasmid
DNA was isolated as described by Leenhouts et al. (23). L. lactis was
transformed by electroporation as described by Holo and Nes (24). For
sequencing, plasmids were transformed to and propagated in E. coli
DH5a. Nucleotide sequences were determined on a Vistra 725 or Ap-
plied Biosystems 373A automated sequencer.
Cloning and Sequencing of the mleP Gene
Plasmid p153A has been described before (25) and was shown to
contain mleS encoding malolactic enzyme and the 59 part of a second
open reading frame ORF2, presumably mleP encoding the malate trans-
porter. A 3-kb fragment obtained by BamHI digestion of chromosomal
DNA isolated from L. lactis IL1441 overlapped with the insert in p153A.
The fragment was cloned into the unique BamHI restriction site of
plasmid pUC18 (26) yielding p191A. Unidirectional sets of nested de-
letions of p191A were constructed using exonuclease III (Pharmacia
Biotech Inc.). Truncated fragments were sequenced using vector-spe-
cific primers after which internal primers were designed to sequence
the remaining regions of each strand. The insert contained the first
1,068 base pairs of ORF2. To clone the missing 39 end of ORF2, an
EcoRI/BamHI fragment of p191A containing the final 900 base pairs of
the ORF2 fragment was used to probe a HindIII digest of chromosomal
DNA. The sequence of a 2.5-kb fragment that hybridized with the probe
was determined using inversed polymerase chain reaction (PCR).
Genomic DNA of L. lactis IL1441 digested with HindIII was ligated
with T4 DNA ligase under conditions that favored the formation of
monomeric circles. The circular fragments were used as a template for
a PCR using oligonucleotides based on the sequence of the EcoRI/
BamHI fragment of p191A. The primer sequences were 59-TGGCAGG-
TATTGGTCTTG-39 and 59-CCATACCACCTGACATCAT-39. A 2-kb
fragment presenting a head to tail structure was amplified and cloned
into pGEM-T (Invitrogen) to give vector pPNJ. The missing 0.4-kb
fragment of ORF2 on pPNJ was sequenced on both strands. ORF2 was
amplified from genomic DNA using a forward primer based on the
sequence of p153A (59-ATCTCGAGATGAAAAAACTTAAAGAA-39) and
a reverse primer based on the sequence of pPNJ (59-GATAGGCGATAT-
AGTCCC-39) and ligated into pGEM-T, yielding pPME. The sequence of
ORF2 reconstructed from all of the fragments was confirmed by se-
quencing one strand of the pPME insert.
Construction of Expression Vectors
An expression vector was constructed containing a promoter region
that is located in front of the citP gene on the 7.9-kb plasmid of L. lactis
NCDO176 (27). The 1,572-base pair region was amplified from the
plasmid by PCR. The forward primer, 59-GCTTAGAATTCCTTGCTAT-
CAGTATGTC-39, introduced an EcoRI restriction site in the fragment.
The reverse primer, 59-GGTGGATCCACATGTTTCTATCTCCATT-
TATATC-39, overlapped with the citP start codon and introduced a
unique AflIII site (ACATGT) around the start codon and a BamHI site
at the end. Bases introducing mutations are underlined, and the start
codon is indicated in bold. The PCR product was digested with EcoRI
and BamHI and ligated into plasmid pGK13 (28) digested with the
same enzymes. The resulting plasmid pMB contains the L. lactis citP
promoter region followed by a ribosomal binding site and an AflIII
restriction site around the start codon. Downstream of the AflIII re-
striction site a number of unique restriction sites are present for cloning
purposes.
The gene coding for the malate transporter mleP was amplified by
PCR from chromosomal DNA isolated from L. lactis IL1403. The
forward primer, 59-TCTTAATCCATGGGAAAAAAACTTAAAGAAAC-
GAAAATATCGG-39, generated an NcoI site around the start codon, and
the reverse primer, 59-TGCTCTAGATTACGCGTATACAAAGAATCG-
GATAAGAATTCCACC-39, generated an XbaI site downstream of the
stop codon. Start and stop codons are indicated in bold. Similarly, the
gene coding for the citrate transporter citP was amplified from an
endogenous plasmid preparation of L. mesenteroides while creating
unique NcoI and XbaI restriction sites around the start codon and
downstream of the stop codon, respectively. The forward primer was
59-GATAGAACCATGGTGAATCACCCGCATTC-39 and the reverse
primer 59-CTTTAAATATCTAGATTACTTCATG-39. The amplified
fragments were digested with NcoI and XbaI and ligated into the AflIII
and NheI sites of pMB which have compatible overhangs. The resulting
vectors pMBmleP and pMBcitP code for mleP and citP under control of
the citP promoter. In case of MleP, the cloning procedure resulted in a
Gly insertion after position 1, and the COOH-terminal Tyr residue was
replaced by Val-Tyr-Ala. In CitP Met2 was replaced by Val. The se-
quence of the inserts was confirmed by automated sequencing.
Preparation of Membrane Vesicles and Hybrid Membranes
Cells of L. lactis MG1363 or LL108 expressing either MleP or CitP
were harvested at the end of the exponential growth phase at an A660 of
0.8, washed with 50 mM potassium phosphate, pH 7.0, resuspended in
the same buffer at an A660 of 500, and subsequently rapidly frozen in
liquid nitrogen until use. Rightside-out membrane vesicles were pre-
pared by the osmotic shock lysis procedure essentially as described by
Otto et al. (29). The membranes were fused to liposomes or to proteoli-
posomes containing beef heart cytochrome c oxidase (COVs) essentially
as described by Driessen et al. (30). Liposomes consisted of a mixture of
purified E. coli lipids and egg yolk phosphatidylcholine at a ratio of 3:1.
E. coli lipids were purified by successive washing of an E. coli extract
(Avanti Polar Lipids) with acetone and diethyl ether, after which the
concentration was determined as described by Driessen et al. (31).
Cytochrome c oxidase isolated from beef heart mitochondria was recon-
stituted into liposomes by detergent dialysis. Liposomes or COVs were
fused with the membrane vesicles of L. lactis at a ratio of 10 mg of lipid
and 1 mg of protein by a single freeze/thaw step (30). The buffer
contained 50 mM potassium phosphate, pH 6. In case of fusion with
liposomes 5 mM L-malate or citrate was included in the buffer to load the
vesicles. The resulting hybrid membranes were made unilamellar by
subsequent extrusion through 400- and 200-nm pore size polycarbonate
filters (32). Hybrid membranes were concentrated by ultracentrifuga-
tion at 250,000 3 g for 20 min at 10 °C.
Rightside-out membrane vesicles of E. coli strain BL21(DE3) ex-
pressing CitS from pSKDLcitS (17) were prepared by the osmotic lysis
procedure essentially as described by Kaback (33) with the following
modification. Spheroplasts were lysed in 50 mM potassium phosphate,
pH 7, containing 5 mM potassium citrate to load the vesicles with
citrate. All subsequent steps were done in the presence of 5 mM potas-
sium citrate. Before use the membrane vesicles were washed once in 15
volumes of potassium phosphate, pH 6, containing 5 mM citrate and
appropriate concentrations NaCl and KCl and concentrated by centrif-
ugation for 20 min in a Eppendorf tabletop centrifuge operated at full
speed. Protein concentrations were determined as described by Lowry et
al. (34).
Transport Assays
Pmf-driven Uptake in Hybrid Membranes—The experiments were
performed in 50 mM potassium phosphate, pH 6.0, under a flow of water
saturated air and continuous stirring at 30 °C. Membrane vesicles
fused with COVs were incubated for 1 min in the presence of 200 mM
TMPD, 20 mM cytochrome c (horse heart, Sigma), and 10 mM potassium
ascorbate. The assay volume was 100 ml and the membrane protein
concentration 0.6–0.8 mg/ml. Valinomycin and nigericin were used at
concentrations of 1 mM and 0.5 mM, respectively. L-[1,4(2,3)14C]malate or
2-Hydroxycarboxylate Transporters 18141
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[1,5-14C]citrate was added at a concentration of 13.1 or 4.4 mM, respec-
tively. Uptake was stopped at different time intervals by adding 2 ml of
ice-cold 0.1 M LiCl to a sample and rapid filtration over 0.45-mm pore
size cellulose nitrate filters (Schleicher & Schuell). Filters were rinsed
once with 2 ml of ice-cold 0.1 M LiCl and transferred to scintillation
vials, and the internalized radioactivity was determined.
Exchange in Membrane Vesicles—Membrane vesicles of L. lactis
LL108 fused to liposomes and E. coli rightside-out membrane vesicles
preloaded with 5 mM L-malate or citrate were concentrated by centrif-
ugation. Strain LL108 was used for this assay because of the higher
expression of MleP and CitP in this strain. Concentrated hybrid mem-
branes were incubated in 50 mM potassium phosphate, pH 6, with 50 mM
nigericin with 72.5 mM [1,5-14C]citrate or 186.7 mM L[1,4(2,3)14C]malate
for 30 min at room temperature. When indicated, 100 mM valinomycin
or 100 mM KSCN was present in the assay mixture. Similarly, the
concentrated E. coli membranes were incubated in 50 mM potassium
phosphate, pH 6, in the presence of 100 mM valinomycin and 50 mM
nigericin with 217.5 mM [1,5-14C]citrate and the appropriate concentra-
tions of NaCl and KCl for 2 h. Aliquots of 2 ml were diluted 100-fold into
buffer of 20 C containing various substrates at a concentration of 5 mM.
The buffer contained 100 mM KCl in the case the membranes where
preloaded with KSCN. Final membrane protein concentrations in the
assays were 0.1–0.15 mg/ml and 0.23 mg/ml for L. lactis hybrid mem-
branes and E. coli membranes, respectively. Samples were stopped and
processed as described above. The data were fitted to an exponential
decay. Within one set of experiments, the zero time point was deter-
mined from the curve representing efflux which is slow enough to allow
a linear back extrapolation. The infinite time point was estimated from
curves representing rapid exchange, usually homologous exchange.
Chemicals
[1,5-14C]Citrate (115 mCi/mmol) and L-[1,4(2, 3)14C]malate (51 mCi/
mmol) were obtained from Amersham International (Buckinghamshire,
U. K.). Oligonucleotides were obtained from Eurosequence (Groningen,
The Netherlands) and from Eurogentec (Seraing, Belgium). All other
compounds were obtained from commercial sources.
RESULTS
Cloning and Sequencing of mleP—In a previous paper the
cloning and sequencing were reported for the gene mleS encod-
ing malolactic enzyme, the decarboxylase in the malolactic
FIG. 1. Alignment of the primary se-
quences of MleP, CitP, and CitS. Iden-
tical residues are printed in gray boxes.
Residues conserved in all three transport-
ers are indicated by an asterisk. Putative
transmembrane segments (17) are indi-
cated by bars.
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fermentation pathway of L. lactis (25). One of the clones con-
tained the 59 end of a second ORF starting 15 base pairs
downstream of the stop codon of mleS. It was suggested that
this ORF would be mleP coding for the malate transporter, the
second protein of the pathway. The complete second reading
frame, 1,278 base pairs in length, was cloned as described
under “Experimental Procedures,” and the nucleotide sequence
was determined. A putative Shine-Dalgarno sequence AAGG is
found 16 nucleotides upstream of the start codon (ATG). The
stop codon (TAA) is followed closely by an inverted repeat that
has features typical of a putative rho-independent transcrip-
tion termination signal (35). This organization suggests that
the two genes are organized in an operon. To verify this, total
RNA was isolated from L. lactis IL1441 grown in medium on
glucose with and without additional malate. Malolactic enzyme
coded by mleS is an inducible enzyme (18). The results demon-
strated that in malate-grown cells a single transcript of approx-
imately 3 kb hybridized with a probe specific for mleP and with
plasmid p191A containing mleS and a 59 fragment of mleP. No
band was detected when malate was omitted from the growth
medium (not shown). The mleP sequence is available under
accession number X75982.
Analysis of the deduced MleP amino acid sequence reveals a
hydrophobic protein of 425 amino acid residues with a pre-
dicted mass of 46.7 kDa. Screening of the available data bases
showed that the protein revealed homology to the citrate trans-
porters of lactic acid bacteria (CitPs) and to the Na1-dependent
citrate carriers of K. pneumoniae (CitS), Salmonella pullorum
(CitC), and Salmonella dublin (CitC). Like the lactococcal
CitPs, the Na1-dependent transporters form a group of pro-
teins with almost identical primary sequences (.95%). The
alignment of MleP with representative sequences from these
two groups is shown in Fig. 1. MleP is most similar to CitP with
48% identical residues and shares 30% sequence identity with
CitS. Overall, the alignment shows 86 (19%) conserved resi-
dues with an additional 85 similar residues. A glycine-rich
region around residue 175 in MleP and approximately the
COOH-terminal 60 residues are the most conserved regions in
the family. Fig. 2 shows the hydropathy profiles of the individ-
ual members (thin lines) and the average profile of the family
(bold). The profiles are remarkably similar, indicative of the
same global structure.
Functional Expression of MleP—To determine whether the
cloned gene identified as mleP is the malate transport protein
involved in malolactic fermentation, the gene was expressed in
L. lactis MG1363 and LL108, strains not able to ferment
malate. Cytoplasmic membranes with a rightside-out orienta-
tion prepared from L. lactis MG1363 harboring pMBmleP (see
“Experimental Procedures”) were fused to proteoliposomes re-
constituted with purified beef heart cytochrome c oxidase
(COVs) as a pmf-generating system. In these hybrid mem-
branes a pmf (inside negative and alkaline relative to the
outside) is generated in the presence of the electron donor
system potassium ascorbate, TMPD, and cytochrome c. In the
presence of a pmf the hybrid membranes took up a low but
significant amount of [14C]malate (Fig. 3A, E). Control exper-
iments with hybrid membranes prepared from membrane ves-
icles of strain MG1363 without pMBmleP showed no uptake
under identical conditions (not shown). Therefore, the product
of the mleP gene is a malate transporter. The pmf generated by
cytochrome c oxidation is composed of a membrane potential
(Dc) and a pH gradient (DpH). The role of each component of
the pmf in driving [14C]malate uptake was investigated by
manipulating DpH and Dc with the ionophores nigericin, a
K1/H1 antiporter, and valinomycin, a K1 pore. In the presence
of nigericin, when the pmf consists solely of a membrane po-
tential, no uptake was observed, indicating that the membrane
potential is not a driving force for malate transport (f). On the
other hand, in the presence of valinomycin, when the pmf is
composed solely of a pH gradient, a strong stimulation of
malate uptake was observed, indicating that the membrane
potential counteracts malate transport () and that net nega-
tive charge is translocated across the membrane during
turnover.
A second important feature of the malate carrier involved in
malolactic fermentation is the physiological mode of transport,
i.e. heterologous malate/lactate exchange (3). Rightside-out
membrane vesicles of L. lactis LL108 harboring pMBmleP were
fused with liposomes and preloaded with 5 mM L-[14C]malate.
100-fold dilution of the membranes in buffer did not result in
significant release of label within the first 40 s, indicating that
efflux of malate down a concentration gradient is a slow process
FIG. 2. Hydropathy profile of MleP, CitP, and CitS. The individ-
ual profiles (thin) and average profile (bold) were calculated with a
window of 21 residues and the normalized hydrophobicity scale of Kyte
(42). Putative transmembrane segments are indicated by bars (17).
FIG. 3. Malate uptake in the pres-
ence of a pmf (panel A) and exchange
(panels B and C) catalyzed by MleP.
Panel A, malate (13.1 mM) uptake by
membrane vesicles of MG1363/pMBmleP
fused with COVs was assayed in the pres-
ence of the electron donor system cyto-
chrome c/TMPD/potassium ascorbate. E,
no ionophores; , valinomycin; and f, ni-
gericin. Panels B and C, membrane vesi-
cles of L. lactis LL108 expressing MleP,
fused with liposomes were preloaded with
5 mM L[14C]malate with (panel C) and
without (panel B) 100 mM KSCN and sub-
sequently diluted 100-fold into buffer con-
taining 5 mM lactate (M), malate (), or no
additions (E). Valinomycin (panel B) and
nigericin (panels B and C) were present at
1 and 0.5 mM, respectively.
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(Fig. 3B, E). In contrast, dilution of the preloaded membranes
in buffer containing an equimolar concentration of unlabeled
malate resulted in rapid release of internal labeled malate,
indicative of rapid homologous exchange (). Most importantly,
the same rapid release of label was observed upon dilution into
buffer containing an equimolar concentration of lactate (M). To
prevent the formation of DpH or Dc which would counteract
efflux, the ionophores valinomycin and nigericin were included
in these experiments. Preloading of the membranes with the
membrane permeable ion SCN2 results in the generation of a
diffusion potential, negative outside, upon dilution when vali-
nomycin is omitted from the assay mixture. The diffusion po-
tential significantly inhibited malate/lactate exchange whereas
malate/malate exchange was not affected (Fig. 3C) showing
that heterologous exchange is electrogenic. The results are
consistent with those found for malate transport in membrane
vesicles of the wild type malate-fermenting L. lactis IL1403 (3)
showing that the mleP gene product is the malate transporter
involved in malolactic fermentation.
Substrate Specificity of MleP, CitP, and CitS—The heterolo-
gous exchange assay demonstrated in Fig. 3B provides a sen-
sitive and unambiguous assay for the substrate specificity of a
transporter in general and was used to determine the substrate
specificity of MleP and the two other representatives of the
family, CitP of L. mesenteroides and CitS of K. pneumoniae. To
use the assay it is essential that efflux is much slower than
exchange. This condition is a property of precursor/product
exchangers (2) and has also been demonstrated for CitP (9). In
case of CitS, conditions of rapid exchange/slow efflux were
sought by varying the concentration of the symported Na1 ion
(Fig. 4). With no additional Na1 added, efflux and exchange in
rightside-out membrane vesicles of E. coli BL21(DE3) harbor-
ing plasmid pSKDlcitS (17) were observed at comparable rates.
Since no effort was made to work “sodium free” the observed
activities are most likely caused by sodium ion contaminations
in the buffer (15). Addition of 1 mM Na1 increased both the rate
of efflux and exchange. However, at 75 mM added Na1 the rate
of exchange increased further, but the rate of efflux decreased.
This behavior is typical for a solute/co-ion symporter (36). The
latter condition was used for the substrate specificity assay.
From previous studies it was known that MleP transports
both malate and lactate, CitP transports citrate, lactate, and
malate (9), whereas for CitS no substrate other than citrate has
been reported. These substrates all share the 2-hydroxycar-
boxylate motive, R1R2COHCOO
2. The effect of the R1 and R2
groups, the hydroxyl group, and the carboxylate group on the
ability of the three transporters to translocate the substrates
was investigated subsequently.
The R Substituents—Nine different 2-hydroxycarboxylates
with R substituents which differ both in size and polarity were
included in the assay. The results are summarized in Table I.
The main conclusion is that CitS is very specific, transporting
only citrate and to a low extent citromalate, whereas MleP and
CitP transport a wide variety of these substrates. MleP has a
preference for the smaller substrates, whereas CitP seems to
prefer the larger molecules. In contrast to CitP, MleP does not
transport citrate and only poorly citromalate, whereas CitP
even transports isocitrate, which has the largest substituent, at
a low but significant rate. At the other end of the spectrum,
glycolate is a good substrate of MleP and a poor substrate of
FIG. 4. Effect of the sodium ion con-
centration on homologous exchange
and efflux catalyzed by CitS. RSO
membrane vesicles of E. coli BL21(DE3)
expressing CitS were preloaded with 5
mM [14C]citrate and with no further addi-
tions (panel A), with 1 mM NaCl (panel B),
and with 75 mM NaCl (panel C). The Cl2
concentration was kept constant by add-
ing compensating amounts of KCl. The
membranes were diluted 100-fold into
buffer containing the same NaCl and KCl
concentrations, in the presence () or the
absence (E) of 5 mM citrate. Valinomycin
and nigericin were present at 1 and 0.5
mM, respectively.
TABLE I
Effect of the R substituents on the ability of MleP, CitP, and CitS to transport 2-hydroxycarboxylates
Substratea R1 R2




2 H 0.4 6 0.2 2.6 6 0.4 1.5 6 0.7
Citrate CH2COO
2 CH2COO
2 0.5 6 0.3 100 6 8 100 6 6
Citromalate CH2COO
2 CH3 6.9 6 1.0 32 6 1 4.6 6 0.5
Tartrate CHOHCOO2 H 18 6 1 7.1 6 0.2 0.9 6 0.5
Malate CH2COO
2 H 100 6 8 142 6 6 1.6 6 0.8
2-Hydroxybutyrate CH2CH3 H 15 6 3 54 6 1 1.3 6 0.4
2-Hydroxyisobutyrate CH3 CH3 16 6 3 100 6 1 1.9 6 0.7
Lactate CH3 H 91 6 14 36 6 1 1.7 6 0.5
Glycolate H H 26 6 8 3.3 6 0.5 1.7 6 0.8
None 0.5 6 0.3 1.0 6 0.5 1.0 6 0.6
a Substrates were added at a concentration of 5 mM. Equal mixtures of the L- and D-isomers were used.
b Rates are relative to the rate observed for homologous exchange, which was set at 100%. These rates varied per vesicle preparation between
2.7 and 4.8, 0.7 and 0.8, and 2.3 and 2.6 mM/s for MleP, CitP, and CitS, respectively. Rates are given as the average of two to four independent
measurement and the S.D.
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CitP. No clear discrimination is evident between substituents
with a polar and a hydrophobic character.
The Hydroxyl Group—A set of compounds was selected in
which the hydroxyl group of one of the transported substrates
listed in Table I was replaced by another substituent. In line
with the high specificity of CitS reported above, none of these
compounds was transported by CitS (Table II). Substrates in
which the hydroxyl group is replaced by a hydrogen atom are
not transported. Similarly, the hydroxyl cannot be replaced by
an amino group. Replacement of the hydroxyl group by a keto
group resulted in significant transport in the case of oxaloace-
tate, especially by MleP. This transporter could also transport
glyoxylate, the 2-oxo analog of glycolate, at a significant rate,
whereas the rate catalyzed by CitP was very low but signifi-
cant. The latter was also observed for pyruvate, the 2-oxocar-
boxylate analog of lactate, for both MleP and CitP. The posi-
tion of the hydroxyl group relative to the caboxylate group
was investigated by comparing 2-hydroxybutyrate and 3-hy-
droxybutyrate. A low but significant transport activity with
the latter substrate was observed with CitP but not with
MleP. In conclusion, MleP and CitP have the highest activity
with 2-hydroxycarboxylates, but significant activity is ob-
served with some 2-oxocarboxylates and in case of CitP even a
3-hydroxycarboxylate.
The Carboxylate Group—Three different analogs of lactate
with different substituents replacing the carboxylate group
were tested in the exchange assay (Table III). A common fea-
ture of the analogs 1,2-propanediol, methyllactate, and glycer-
aldehyde is that the charge of the carboxylate is removed. In
addition to the aldehyde group replacing the carboxylate, glyc-
eraldehyde has a hydroxyl group at the C3 position. This might
have an additional effect on the suitability as a substrate, but,
on the other hand, tartrate, an analog of malate, has the same
feature and is transported both by MleP and CitP (Table I).
None of the analogs was transported by any of the transporters,
emphasizing the relevance of the carboxylate group in the
motif.
DISCUSSION
Secondary pmf-generating pathways were discovered only in
the last decade. Oxalate decarboxylation in Oxalobacter formi-
genes and malolactic fermentation in L. lactis were the first
systems described in detail (3, 6). Both pathways consist of only
two enzymes, a secondary transporter and a cytoplasmic decar-
boxylase. The secondary transporters that take up the sub-
strate in exchange for the decarboxylation product (precursor/
product exchange) and, thereby, generate the membrane
potential play a central role in the pathways. Recently, the
structural gene coding for the oxalate/formate exchanger OxlT
of O. formigenes was cloned and sequenced (37). Here, we
report the cloning and sequencing of MleP, the malate/lactate
exchanger of L. lactis. The cloned gene was expressed in the
malolactic fermentation-negative L. lactis strains MG1363 and
LL108. Functional characterization in membrane vesicles de-
rived from these cells showed that the gene product conferred
the same transport characteristics as was observed before in
membrane vesicles of the malate-fermenting wild type strain
IL1403 (3). The cloned transporter catalyzed efficient heterol-
ogous malate/lactate exchange, and unidirectional uptake into
the membranes was counteracted by the membrane potential.
The mleP gene of L. lactis is not homologous to the oxlT gene
of O. formigenes, indicating that genes coding for membrane
potential-generating secondary transporters do not form a sep-
arate gene family. MleP was found to be homologous to the
membrane potential-generating citrate transporter CitP of lac-
tic acid bacteria and the Na1-dependent citrate transporters
CitS (13) and CitC (38) of K. pneumoniae and Salmonella
species. The homology to CitS and CitC which are metabolic
energy-dissipating transporters suggests that MleP and CitP,
and membrane potential-generating secondary transporters in
general, are conventional secondary transporters. The mem-
brane topology of CitS was recently reported to be quite differ-
ent from the transmembrane 12-helix motif usually observed
for secondary transporters (17). CitS traverses the membrane 9
times (the bars in Fig. 1) with a cytoplasmic amino terminus
and a periplasmic carboxyl terminus. The sequence homology
and the highly conserved hydropathy profile of the members in
the family strongly suggest that MleP and CitP fold in a similar
fashion in the membrane. In this structural model the two most
conserved regions in the alignment shown in Fig. 1 are located
in the periplasmic loop between helices V and VI and the
cytoplasmic loop preceding the COOH-terminal helix IX. The
alignment shows 6 conserved positively charged amino acid
residues of which only Arg-407 (MleP numbering) is predicted
to be located in the membrane, in putative helix IX. Since
MleP, CitP, and CitS transport negatively charged substrates
this Arg residue could play a role in substrate binding and/or
transport.
Previous studies had shown that MleP, CitP, and CitS trans-
port one or more of the structurally related substrates citrate,
malate, and lactate (3, 9, 14), and it was noted that these
substrates all contain the motif R1R2COHCOO
2 (9). In the
present study the importance of the hydroxyl and carboxylate
groups of the substrates was investigated. None of a limited
number of lactate analogs in which the carboxylate group was
TABLE II
Effect of OH substituents on the ability of MleP, CitP, and CitS to
transport a substrate
Details are in the legend to Table I.
Substrate OHsubstituent
Relative rate of exchange
MleP CitP CitS
%
Citrate OH 0.5 6 0.3 100 6 8 100 6 6
Tricarballate H 1.0 6 0.2 2.2 6 0.7 1.0 6 0.1
Malate OH 100 6 8 142 6 6 1.6 6 0.8
Succinate H 0.4 6 0.1 0.5 6 0.3 1.0 6 0.5
Oxaloacetate O 27 6 4 14 6 1 1.5 6 0.8
Aspartate NH3
1 0.7 6 0.3 1.3 6 0.3 0.8 6 0.5
Lactate OH 91 6 14 36 6 1 1.7 6 0.5
Propionate H 0.5 6 0.1 0.7 6 0.3 1.3 6 0.4
Pyruvate O 1.2 6 0.3 4.2 6 0.7 1.9 6 0.8
Alanine NH3
1 0.6 6 0.2 0.6 6 0.2 0.7 6 0.4
Glycolate OH 26 6 8 3.3 6 0.5 1.7 6 0.8
Acetate H 0.5 6 0.3 0.3 6 0.2 1.0 6 0.5
Glyoxylate O 13 6 2 2.2 6 0.2 0.9 6 0.5
Glycine NH3
1 0.7 6 0.3 1.1 6 0.3 0.9 6 0.5
2-Hydroxybutyrate OH on C2 15 6 3 54 6 1 1.3 6 0.4
3-Hydroxybutyrate OH on C3 1.1 6 0.5 3.9 6 0.2 1.5 6 0.6
None 0.5 6 0.3 1.0 6 0.5 1.0 6 0.6
TABLE III
Effect of COO2 substituents on the ability of MleP, CitP, and CitS to
transport a substrate




Relative rate of exchange
MleP CitP CitS
%
Lactate COO2 91 6 14 36 6 1 1.7 6 0.5
Methyl-L-lactate COOCH3 1.0 6 0.1 0.8 6 0.1 1.3 6 0.4
1,2-Propanediol CH2OH 0.4 6 0.3 0.4 6 0.2 1.3 6 0.4
Glyceraldehyde CHO 0.9 6 0.5 0.7 6 0.5 1.1 6 0.5
None 0.5 6 0.3 1.0 6 0.5 1.0 6 0.6
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methylated or replaced by an hydroxyl or aldehyde group could
be translocated by any of the transporters. This suggests that
the carboxylate and possibly the negative charge of this group
are essential. A larger number of analogs showed that replace-
ment of the hydroxyl group by a hydrogen atom or an amino
group completely abolished transport activity (Table II). How-
ever, replacement by a keto group resulted to some extent in
activity with MleP and CitP, especially with oxaloacetate. Mov-
ing the hydroxyl to the C3 position resulted in a low transport
activity by CitP. Possibly, hydrogen bonding between a residue
on the transporter and the hydroxyl or keto group on the
substrates is essential for translocation. The transport activity
of CitP with oxaloacetate is remarkable since oxaloacetate is
the first metabolic intermediate in the citrate degradation
pathway in lactic acid bacteria (39). Since the 2-hydroxycar-
boxylates are the physiological and preferred substrates of
these carriers we have termed the family the 2-hydroxycar-
boxylate transporter family.
A typical feature of membrane potential-generating second-
ary transporters like MleP and CitP is the ability to translocate
two structurally related substrates, i.e. malate/lactate and ci-
trate/lactate, respectively. The transporters specifically recog-
nize the common 2-hydroxycarboxylate motif. At the same
time, MleP and CitP need to be quite tolerant toward the R1
and R2 groups since the cytoplasmic conversion of the substrate
into the product not only results in a smaller molecule but also
removes the charge on one of the R groups. Charge removal is
crucial and results in the generation of the membrane poten-
tial. A similar tolerance toward the R groups is not a physio-
logical requirement for the Na1-dependent citrate transporter
CitS that functions as a Na1/H1 symporter (14–16). Consistent
with this observation, the results in Table I show that CitS has
a very narrow substrate specificity (mainly citrate), whereas
MleP and CitP transport a wide range of 2-hydroxycarboxyl-
ates with different R substituents. Remarkably, the R groups of
the transported substrates range in size from the smallest
possible, i.e. hydrogen atoms in glycolate, to the R groups of the
physiological substrates, i.e. malate for MleP and citrate for
CitP. Larger R groups as in citromalate for MleP and isocitrate
for CitP result in very poor translocation. Apparently, the
translocation site is optimized for the physiological substrates,
and smaller R groups are compensated for by the conformation
of the protein or a varying amount of cotransported water (40,
41). In the case of CitS smaller R groups reduce transport
drastically, possibly because the R groups are essential for Na1
binding.
The members of the 2-hydroxycarboxylate transporter fam-
ily are a potent experimental system to study the relation
between the primary sequence and substrate specificity. Cur-
rently, we are dissecting the binding and translocation events
kinetically, analyzing the stereo selectivity of the transporters,
and identifying residues in the primary sequences which are
located in the binding pockets of MleP, CitP, and CitS. Such
studies will eventually give a detailed model of the binding
sites and explain how the details in similar structures result in
important functional differences.
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